Brief: Active Biotech Q2 Operating Loss Widens To SEK 10.1 Mln

Active Biotech AB publ

06/08/2020 07:47

Aug 6 (Reuters) - Active Biotech AB (publ)  ACTI.ST :
    * Q2 OPERATING LOSS SEK 10.1 MILLION VERSUS LOSS SEK 5.4
MILLION
YEAR AGO
    * Q2 NET SALES AMOUNTED TO SEK 0.0 M (1.1)

Source text for Eikon:  ID:nGNE3dwB6p 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))